Sinovac's Covid vaccine sales nosedive; Gracell trims pipeline, starts lupus study
China-based pharma Sinovac has seen a stark falloff in sales since last year.
In Sinovac’s financial disclosures for the first half of the year, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
